RPL31P3

Across TCGA pan-cancer cohorts, RPL31P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL31P3’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RPL31P3 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL31P3 is over-expressed in tumor, although a few such as BLCA show the opposite, repressed pattern.

BLCA and LIHC are the cancer types where RPL31P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL31P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	−0.050	.038	2	view →
LIHC	All	All	+0.013	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL31P3–BLCA

Open the BLCA breakdown →